New Substances Added to the Supplementary List of Controlled Non-Medical Use Narcotics and Psychotropic Drugs | regulatory trends

Recently, the Ministry of Public Security, the National Health Commission, and the National Medical Products Administration, in accordance with the "Regulations on the control of Narcotic Drugs and Psychotropic substances" and the "Management Measures for Non-Medical Use Narcotics and Psychotropic Drugs," jointly issued the "Announcement on the Inclusion of 46 Substances, including Brorphine, in the Supplementary List of Controlled Non-Medical Use Narcotics and Psychotropic Drugs". The notice will come into effect on July 1, 2024.

The 46 newly included substances in the "Supplementary Catalogue of Controlled Non-Medical Use Narcotics and Psychotropic Drugs" mainly include Brorphine, Metonitazene, 2-Methyl-AP-237, and Etazene, among others. For details, please see the attachment.

Attachment

Announcement on the Inclusion of 46 Substances, including Brorphine, in the Supplementary List of Controlled Non-Medical Use Narcotics and Psychotropic Drugs

ChemRadar Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: ChemRadar" on this website are copyrighted by ChemRadar. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: ChemRadar" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: ChemRadar" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on ChemRadar raises copyright or other related issues, please contact us within two weeks.